SNDL Inc
F:VY4

Watchlist Manager
SNDL Inc Logo
SNDL Inc
F:VY4
Watchlist
Price: 1.155 EUR -2.12% Market Closed
Market Cap: 305.2m EUR

EV/EBITDA
Enterprise Value to EBITDA

11.7
Current
-11.7
Median
12.4
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
11.7
=
Enterprise Value
227.4m EUR
/
EBITDA
30.5m CAD
Market Cap EV/EBITDA
CA
SNDL Inc
F:VY4
297.2m EUR 11.7
US
Eli Lilly and Co
NYSE:LLY
696.8B USD 33.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 3 846.3
US
Johnson & Johnson
NYSE:JNJ
369.7B USD 12.4
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK 13.2
CH
Roche Holding AG
SIX:ROG
209B CHF 9.5
CH
Novartis AG
SIX:NOVN
183.5B CHF 10.2
UK
AstraZeneca PLC
LSE:AZN
163.1B GBP 130.7
US
Merck & Co Inc
NYSE:MRK
195.6B USD 8.4
IE
Endo International PLC
LSE:0Y5F
163.5B USD 261.3
US
Pfizer Inc
NYSE:PFE
133.1B USD 7.3
EBITDA Growth EV/EBITDA to Growth
CA
SNDL Inc
F:VY4
Average EV/EBITDA: 395
11.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
33.8
31%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.4
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
14%
0.9
CH
Roche Holding AG
SIX:ROG
9.5
6%
1.6
CH
Novartis AG
SIX:NOVN
10.2
5%
2
UK
AstraZeneca PLC
LSE:AZN
130.7
9%
14.5
US
Merck & Co Inc
NYSE:MRK
8.4
9%
0.9
IE
E
Endo International PLC
LSE:0Y5F
261.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.3
2%
3.7

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
20
2-Years Forward
EV/EBITDA
3.6
3-Years Forward
EV/EBITDA
N/A